This Article contains a typographical error in the grant number in the Acknowledgements section.
“We would like to acknowledge our funding source: the Key Program of National Natural Science Foundation of China (No. 81370126)”
should read:
“We would like to acknowledge our funding source: the Key Program of National Natural Science Foundation of China (No. 81130001)”
Additional information
The online version of the original article can be found at 10.1038/srep08191
Rights and permissions
About this article
Cite this article
Lai, T., Wang, S., Xu, Z. et al. Correction: Corrigendum: Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis. Sci Rep 5, 9548 (2015). https://doi.org/10.1038/srep09548
Published:
DOI: https://doi.org/10.1038/srep09548
